Figure 4

Significant downregulation of the mean expression levels of (a) MCM-2, (b) Ki-67, and (c) EGFR in advanced-stage disease of the 15 LSCC patients without recurrence. Data are presented as the mean ± SD. *p < 0.05, **p < 0.01.

Significant downregulation of the mean expression levels of (a) MCM-2, (b) Ki-67, and (c) EGFR in advanced-stage disease of the 15 LSCC patients without recurrence. Data are presented as the mean ± SD. *p < 0.05, **p < 0.01.